These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25000353)

  • 21. Botulinum toxin for the treatment of chronic constipation in children with internal anal sphincter dysfunction.
    Irani K; Rodriguez L; Doody DP; Goldstein AM
    Pediatr Surg Int; 2008 Jul; 24(7):779-83. PubMed ID: 18443801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hirschsprung-Associated Enterocolitis at a Referral Institution: A Retrospective Review.
    Encisco EM; Lim IIP; Velazco CS; Rosen NG; Garrison AP; Rymeski B; Frischer JS
    J Pediatr Surg; 2023 Aug; 58(8):1578-1581. PubMed ID: 37221126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anal achalasia after pull-through operations for Hirschsprung's disease -- preliminary experience with topical nitric oxide.
    Millar AJ; Steinberg RM; Raad J; Rode H
    Eur J Pediatr Surg; 2002 Jun; 12(3):207-11. PubMed ID: 12101506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defecation disorders in children after surgery for Hirschsprung disease.
    Chumpitazi BP; Nurko S
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):75-9. PubMed ID: 21694540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional outcomes in Hirschsprung disease: A single institution's 12-year experience.
    Thakkar HS; Bassett C; Hsu A; Manuele R; Kufeji D; Richards CA; Agrawal M; Keshtgar AS
    J Pediatr Surg; 2017 Feb; 52(2):277-280. PubMed ID: 27912977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease.
    Langer JC; Birnbaum E
    J Pediatr Surg; 1997 Jul; 32(7):1059-61; discussion 1061-2. PubMed ID: 9247234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histology and function of the internal anal sphincter after injection of botulinum toxin.
    Langer JC; Birnbaum EE; Schmidt RE
    J Surg Res; 1997 Dec; 73(2):113-6. PubMed ID: 9441803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of posterior internal anal sphincter myectomy and intrasphincteric botulinum toxin injection for treatment of internal anal sphincter achalasia: a meta-analysis.
    Friedmacher F; Puri P
    Pediatr Surg Int; 2012 Aug; 28(8):765-71. PubMed ID: 22806601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical nitric oxide treatment after pull through operations for Hirschsprung disease.
    Tiryaki T; Demirbağ S; Atayurt H; Cetinkurşun S
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):390-2. PubMed ID: 15735503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin injection into the lacrimal gland for treatment of proximal nasolacrimal duct obstructions in children.
    Eustis HS; Babiuch A
    J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e75-7. PubMed ID: 25427340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new modification of transanal Soave pull-through procedure for Hirschsprung's disease.
    Li AW; Zhang WT; Li FH; Cui XH; Duan XS
    Chin Med J (Engl); 2006 Jan; 119(1):37-42. PubMed ID: 16454980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of the use of botulinum toxin injection for functional anal pain.
    Hollingshead JR; Maeda Y; Brown TJ; Warusavitarne J; Vaizey CJ
    Colorectal Dis; 2011 Sep; 13(9):e293-6. PubMed ID: 21689353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent obstructive symptoms after surgery for Hirschsprung's disease: development of a diagnostic and therapeutic algorithm.
    Langer JC
    J Pediatr Surg; 2004 Oct; 39(10):1458-62. PubMed ID: 15486887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term clinical outcome in patients with Hirschsprung's disease and associated Down's syndrome.
    Menezes M; Puri P
    J Pediatr Surg; 2005 May; 40(5):810-2. PubMed ID: 15937820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative observational study on intrasphincteric injections with Botulinum toxin vs. enteral neuromodulation in chronic refractory constipation.
    Walther M; Müller H; Weiß C; Carbon R; Diez S; Besendörfer M
    BMC Pediatr; 2023 Sep; 23(1):448. PubMed ID: 37684559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botox combined with myofascial release physical therapy as a treatment for myofascial pelvic pain.
    Halder GE; Scott L; Wyman A; Mora N; Miladinovic B; Bassaly R; Hoyte L
    Investig Clin Urol; 2017 Mar; 58(2):134-139. PubMed ID: 28261683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation and management of persistent problems after surgery for Hirschsprung disease in a child.
    Dasgupta R; Langer JC
    J Pediatr Gastroenterol Nutr; 2008 Jan; 46(1):13-9. PubMed ID: 18162828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EUS-guided botulinum toxin injection of the internal anal sphincter in anorectal outlet obstruction.
    Trindade AJ; Hirten R; Greenberg RE; Sejpal DV
    Am J Gastroenterol; 2014 Aug; 109(8):1293-4. PubMed ID: 25091252
    [No Abstract]   [Full Text] [Related]  

  • 39. Restorative proctocolectomy with J-pouch ileoanal anastomosis for total colonic aganglionosis among neonates and infants.
    Hukkinen M; Koivusalo A; Rintala RJ; Pakarinen MP
    J Pediatr Surg; 2014 Apr; 49(4):570-4. PubMed ID: 24726115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin A for children with salivary control problems.
    Montgomery J; McCusker S; Hendry J; Lumley E; Kubba H
    Int J Pediatr Otorhinolaryngol; 2014 Nov; 78(11):1970-3. PubMed ID: 25242701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.